☆ 4.5 Article

Clinical Significance of Circulating Clonal Plasma Cells Detected by a Novel Microfluidic Chip in Multiple Myeloma

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

MRD Assessment in Multiple Myeloma: Progress and Challenges

Luca Bertamini et al.

Summary: In recent years, significant progress has been made in the assessment of MRD in multiple myeloma (MM). Achievement of MRD negativity is considered prognostically important and associated with better survival. Along with established techniques, other methods are under study, and the appropriate use of MRD assessment in therapeutic decision making remains a fascinating and challenging issue for clinicians.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2021)

添加到收藏夹

Article Hematology

Prognostic value of circulating clonal plasma cells in newly diagnosed multiple myeloma

Wenmin Han et al.

Summary: This study found that the presence of CPC in multiple myeloma patients may be associated with poor prognosis. Stratifying patients into different risk groups based on the combination of R-ISS system and CPC level may help predict patient outcomes.

HEMATOLOGY (2021)

添加到收藏夹

Article Oncology

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

Bruno Paiva et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

添加到收藏夹

Article Oncology

High-risk cytogenetics in multiple myeloma: Further scrutiny of deletions within the IGH gene region enhances risk stratification

Scott C. Smith et al.

GENES CHROMOSOMES & CANCER (2020)

添加到收藏夹

Article Oncology

High Oct4 expression: implications in the pathogenesis of neuroblastic tumours

Ezequiel Monferrer et al.

BMC CANCER (2019)

添加到收藏夹

Article Biophysics

Selective isolation and noninvasive analysis of circulating cancer stem cells through Raman imaging

Hyeon-Yeol Cho et al.

BIOSENSORS & BIOELECTRONICS (2018)

添加到收藏夹

Article Cell Biology

Isolation of circulating plasma cells from blood of patients diagnosed with clonal plasma cell disorders using cell selection microfluidics

Joyce W. Kamande et al.

INTEGRATIVE BIOLOGY (2018)

添加到收藏夹

Article Hematology

Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders

Brad Foulk et al.

BRITISH JOURNAL OF HAEMATOLOGY (2018)

添加到收藏夹

Article Oncology

New Developments in Diagnosis, Prognosis, and Assessment of Response in Multiple Myeloma

Ola Landgren et al.

CLINICAL CANCER RESEARCH (2016)

添加到收藏夹

Review Hematology

New criteria for response assessment: role of minimal residual disease in multiple myeloma

Bruno Paiva et al.

BLOOD (2015)

添加到收藏夹

Article Hematology

Quantification of clonal circulating plasma cells in relapsed multiple myeloma

Wilson I. Gonsalves et al.

BRITISH JOURNAL OF HAEMATOLOGY (2014)

添加到收藏夹

Review Oncology

IMWG consensus on risk stratification in multiple myeloma

W. J. Chng et al.

LEUKEMIA (2014)

添加到收藏夹

Article Oncology

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

S. K. Kumar et al.

LEUKEMIA (2012)

添加到收藏夹

Article Oncology

Circulating plasma cells predict the outcome of relapsed or refractory multiple myeloma

Valdas Peceliunas et al.

LEUKEMIA & LYMPHOMA (2012)

添加到收藏夹

Letter Oncology

The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation

K. Vandyke et al.

BLOOD CANCER JOURNAL (2011)

添加到收藏夹

Article Hematology

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

Laurence Lode et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)

添加到收藏夹

Review Biochemistry & Molecular Biology

Unique biomechanical interactions between myeloma cells and bone marrow stroma cells

Yongdong Feng et al.

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2010)

添加到收藏夹

Article Multidisciplinary Sciences

Isolation of rare circulating tumour cells in cancer patients by microchip technology

Sunitha Nagrath et al.

NATURE (2007)

添加到收藏夹

Review Cell Biology

Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias

C Decourt et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.